Heather Glaser Selected Research

Mechanistic Target of Rapamycin Complex 2

7/2011	Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors.
7/2010	Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heather Glaser Research Topics

Disease

6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2013 - 01/2008
3	Leukemia 09/2010 - 01/2008
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2010
1	Premature Aging 02/2009
1	Werner Syndrome (Werner's Syndrome) 02/2009
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2009
1	Emphysema 02/2009

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 05/2013 - 01/2008
3	Aligeron (AS 2)IBA 09/2010 - 01/2008
2	Eukaryotic Initiation Factor-4EIBA 05/2013 - 10/2010
2	Mechanistic Target of Rapamycin Complex 2IBA 07/2011 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 10/2010 - 02/2009
1	cercosporamideIBA 05/2013
1	Sirolimus (Rapamycin)FDA Link 07/2011
1	Mechanistic Target of Rapamycin Complex 1IBA 07/2011
1	Mitogen-Activated Protein KinasesIBA 10/2010
1	Peptide Initiation Factors (Initiation Factor)IBA 10/2010
1	ArsenicIBA 09/2010
1	Beclin-1IBA 09/2010
1	Heavy MetalsIBA 09/2010
1	Amino Acids FDA Link 05/2010
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2010
1	MAP kinase kinase kinase 7IBA 05/2010
1	Small Interfering RNA (siRNA)IBA 05/2010
1	SmokeIBA 02/2009
1	RecQ HelicasesIBA 02/2009
1	Arsenic Trioxide (Trisenox)FDA Link 01/2008
1	TOR Serine-Threonine KinasesIBA 01/2008